Keep Up With McLean!
Receive the latest news in your inbox each month.
This keynote address was part of the 2017 Technology in Psychiatry Summit, sponsored by the McLean Institute for Technology in Psychiatry on November 6-7, 2017, at the JB Martin Conference Center, Harvard Medical School.
Sarah H. Lisanby, MD, is the director of the Division of Translational Research and director of the Noninvasive Neuromodulation Unit at NIMH. Her division supports research to accelerate the translation of scientific discoveries into preventions, treatments, and cures for mental illness, and her individual research focuses on neurostimulation devices and mental illness treatments.
Please visit mclean.org/itp to learn more about the McLean Institute for Technology in Psychiatry.
Back to top